Literature DB >> 35247328

Homotypic fibrillization of TMEM106B across diverse neurodegenerative diseases.

Andrew Chang1, Xinyu Xiang2, Jing Wang1, Carolyn Lee3, Tamta Arakhamia1, Marija Simjanoska1, Chi Wang4, Yari Carlomagno5, Guoan Zhang6, Shikhar Dhingra7, Manon Thierry8, Jolien Perneel9, Bavo Heeman9, Lauren M Forgrave10, Michael DeTure5, Mari L DeMarco10, Casey N Cook5, Rosa Rademakers9, Dennis W Dickson5, Leonard Petrucelli5, Michael H B Stowell11, Ian R A Mackenzie12, Anthony W P Fitzpatrick13.   

Abstract

Misfolding and aggregation of disease-specific proteins, resulting in the formation of filamentous cellular inclusions, is a hallmark of neurodegenerative disease with characteristic filament structures, or conformers, defining each proteinopathy. Here we show that a previously unsolved amyloid fibril composed of a 135 amino acid C-terminal fragment of TMEM106B is a common finding in distinct human neurodegenerative diseases, including cases characterized by abnormal aggregation of TDP-43, tau, or α-synuclein protein. A combination of cryoelectron microscopy and mass spectrometry was used to solve the structures of TMEM106B fibrils at a resolution of 2.7 Å from postmortem human brain tissue afflicted with frontotemporal lobar degeneration with TDP-43 pathology (FTLD-TDP, n = 8), progressive supranuclear palsy (PSP, n = 2), or dementia with Lewy bodies (DLB, n = 1). The commonality of abundant amyloid fibrils composed of TMEM106B, a lysosomal/endosomal protein, to a broad range of debilitating human disorders indicates a shared fibrillization pathway that may initiate or accelerate neurodegeneration. Published by Elsevier Inc.

Entities:  

Keywords:  DLB; FTLD-TDP; PSP; TMEM106B; amyloid fibrils; cryo-EM; endosome; lysosome; neurodegeneration; proteolysis

Mesh:

Substances:

Year:  2022        PMID: 35247328      PMCID: PMC9018563          DOI: 10.1016/j.cell.2022.02.026

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   66.850


  65 in total

1.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

2.  The CamSol method of rational design of protein mutants with enhanced solubility.

Authors:  Pietro Sormanni; Francesco A Aprile; Michele Vendruscolo
Journal:  J Mol Biol       Date:  2014-10-14       Impact factor: 5.469

3.  Posttranslational Modifications Mediate the Structural Diversity of Tauopathy Strains.

Authors:  Tamta Arakhamia; Christina E Lee; Yari Carlomagno; Duc M Duong; Sean R Kundinger; Kevin Wang; Dewight Williams; Michael DeTure; Dennis W Dickson; Casey N Cook; Nicholas T Seyfried; Leonard Petrucelli; Anthony W P Fitzpatrick
Journal:  Cell       Date:  2020-02-06       Impact factor: 41.582

4.  TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers.

Authors:  N Finch; M M Carrasquillo; M Baker; N J Rutherford; G Coppola; M Dejesus-Hernandez; R Crook; T Hunter; R Ghidoni; L Benussi; J Crook; E Finger; K J Hantanpaa; A M Karydas; P Sengdy; J Gonzalez; W W Seeley; N Johnson; T G Beach; M Mesulam; G Forloni; A Kertesz; D S Knopman; R Uitti; C L White; R Caselli; C Lippa; E H Bigio; Z K Wszolek; G Binetti; I R Mackenzie; B L Miller; B F Boeve; S G Younkin; D W Dickson; R C Petersen; N R Graff-Radford; D H Geschwind; R Rademakers
Journal:  Neurology       Date:  2010-12-22       Impact factor: 9.910

5.  Amyloid fibrils in FTLD-TDP are composed of TMEM106B and not TDP-43.

Authors:  Yi Xiao Jiang; Qin Cao; Michael R Sawaya; Romany Abskharon; Peng Ge; Michael DeTure; Dennis W Dickson; Janine Y Fu; Rachel R Ogorzalek Loo; Joseph A Loo; David S Eisenberg
Journal:  Nature       Date:  2022-03-28       Impact factor: 69.504

6.  Regulated intramembrane proteolysis of the frontotemporal lobar degeneration risk factor, TMEM106B, by signal peptide peptidase-like 2a (SPPL2a).

Authors:  Owen A Brady; Xiaolai Zhou; Fenghua Hu
Journal:  J Biol Chem       Date:  2014-05-28       Impact factor: 5.157

7.  TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort.

Authors:  Julie van der Zee; Tim Van Langenhove; Gernot Kleinberger; Kristel Sleegers; Sebastiaan Engelborghs; Rik Vandenberghe; Patrick Santens; Marleen Van den Broeck; Geert Joris; Jolien Brys; Maria Mattheijssens; Karin Peeters; Patrick Cras; Peter P De Deyn; Marc Cruts; Christine Van Broeckhoven
Journal:  Brain       Date:  2011-03       Impact factor: 13.501

8.  New tools for automated high-resolution cryo-EM structure determination in RELION-3.

Authors:  Jasenko Zivanov; Takanori Nakane; Björn O Forsberg; Dari Kimanius; Wim Jh Hagen; Erik Lindahl; Sjors Hw Scheres
Journal:  Elife       Date:  2018-11-09       Impact factor: 8.140

9.  Loss of Tmem106b leads to cerebellum Purkinje cell death and motor deficits.

Authors:  Rosa Rademakers; Alexandra M Nicholson; Yingxue Ren; Shunsuke Koga; Hung Phuoc Nguyen; Mieu Brooks; Wenhui Qiao; Zachary S Quicksall; Billie Matchett; Ralph B Perkerson; Aishe Kurti; Monica Castanedes-Casey; Virginia Phillips; Ariston L Librero; Cristhoper H Fernandez De Castro; Matthew C Baker; Shanu F Roemer; Melissa E Murray; Yan Asmann; John D Fryer; Guojun Bu; Dennis W Dickson; Xiaolai Zhou
Journal:  Brain Pathol       Date:  2021-03-11       Impact factor: 6.508

10.  DeepEMhancer: a deep learning solution for cryo-EM volume post-processing.

Authors:  Ruben Sanchez-Garcia; Josue Gomez-Blanco; Ana Cuervo; Jose Maria Carazo; Carlos Oscar S Sorzano; Javier Vargas
Journal:  Commun Biol       Date:  2021-07-15
View more
  2 in total

Review 1.  Physiological and Pathological Functions of Neuronal Hemoglobin: A Key Underappreciated Protein in Parkinson's Disease.

Authors:  Ran Zheng; Yiqun Yan; Jiali Pu; Baorong Zhang
Journal:  Int J Mol Sci       Date:  2022-08-13       Impact factor: 6.208

Review 2.  Identification of TMEM106B amyloid fibrils provides an updated view of TMEM106B biology in health and disease.

Authors:  Jolien Perneel; Rosa Rademakers
Journal:  Acta Neuropathol       Date:  2022-09-02       Impact factor: 15.887

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.